External PRRC for MedTech SMEs: Your Guide to Regulatory Compliance

For medical device manufacturers, particularly small to medium-sized enterprises, securing a Person Responsible for Regulatory Compliance (PRRC) through an external service is a common strategy for meeting European regulatory requirements. However, selecting the right long-term partner involves more than just a contractual agreement. With potential updates to Post-Market Surveillance and Vigilance (PMSV) reporting systems anticipated around 2026, how can a manufacturer develop a robust evaluation framework to choose a 'PRRC as a Service' provider that is not only qualified for current obligations but also prepared for future regulatory changes? What specific criteria should be used to assess a provider’s expertise, particularly concerning the manufacturer's device class and technology (e.g., active implantable vs. Software as a Medical Device)? Beyond verifying qualifications, what practical questions can reveal how the external PRRC will integrate with the existing Quality Management System, especially for critical processes like technical documentation review and vigilance reporting? Furthermore, how should a manufacturer probe a potential provider’s strategy for managing the upcoming PMSV updates? This could involve asking about their process for monitoring regulatory intelligence, their plans for training on new reporting forms, and how they will ensure a seamless transition for their clients. What contractual terms should be in place to clearly delineate the PRRC's responsibilities from the manufacturer's, especially regarding liability and final sign-off authority for regulatory declarations? Finally, what engagement models are typically offered, and what hidden costs or out-of-scope activities should manufacturers be aware of when comparing service proposals? --- *This Q&A was AI-assisted and reviewed for accuracy by Lo H. Khamis.*